Nuclear Medicine
STANNOUS CHLORIDE
Name:
Stannous Chloride Radiofarma®
Active Principle:
Stannous Chloride
Therapeutic Action:
It is indicated for:
– Performing scintigraphic studies of the blood pool of the heart and great vessels.
– Circulatory and placental studies.
– Evaluation of gastrointestinal bleeding (especially to locate the site of bleeding).
– As a reducing agent, it is used for the “In Vivo” labeling of red blood cells, to the administration of 99mTc, in the form of sodium pertechnetate (99mTc).
– Perform radiocardiogram and radioisotope ventriculogram for evaluation of cardiac ejection fraction with 99mTc.
– The diagnosis of hemangioma.
– The detection of aneurysms.
Nuclear Medicine
STANNOUS CHLORIDE
Name:
Stannous Chloride Radiofarma®
Active Principle:
Stannous Chloride
Therapeutic Action:
It is indicated for:
– Performing scintigraphic studies of the blood pool of the heart and great vessels.
– Circulatory and placental studies.
– Evaluation of gastrointestinal bleeding (especially to locate the site of bleeding).
– As a reducing agent, it is used for the “In Vivo” labeling of red blood cells, to the administration of 99mTc, in the form of sodium pertechnetate (99mTc).
– Perform radiocardiogram and radioisotope ventriculogram for evaluation of cardiac ejection fraction with 99mTc.
– The diagnosis of hemangioma.
– The detection of aneurysms.
RELATED PRODUCTS
-
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases.